Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Michael BROWNELL Joins AcuSurgical SAS As Chairman Of The Board

AcuSurgical, a French startup developing novel robots and procedures for the retina and ophthalmology surgery markets, announces the appointment of Michael BROWNELL as Chairman of the Board.

Recommended AI News: Analog Devices and Keysight Collaborate to Speed Development of O-RAN Solutions

Michael Brownell is a serial entrepreneur in early-stage companies developing new technology, products, and markets. He has served as VP of Product Development for Intralase, Global Head/VP/Director of surgical equipment for AMO (Advanced/Abbott Medical Optics), CEO of Gobiquity, CTO of PowerLase, and other executive positions, Michael received an MS in Physics, Lasers, and Optics from San Diego State University.

Related Posts
1 of 40,467

Michael brings to AcuSurgical 30 years of international experience with innovative businesses and new product development in ophthalmology, to help build a great company that is fast to market with high value solutions, and to establish the company as one of the robotic surgery leaders in ophthalmology.

Recommended AI News: Accenture Positioned as a Leader in Digital Strategy Consulting Services by the IDC MarketScape

AcuSurgical CEO Christoph Spuhler says : “Michael’s experience is an excellent fit to help us with our mission to transform ophthalmic surgery and will be a great addition to the board. We’re excited to have him join the team.”

Investors say : Valerie Calenda, Managing Partner at Merieux Equity Partners: «Michael is well complementing the team, bringing a wealth of experience in the global ophthalmology industry and particularly in the development of innovative products.» Celia Hart, General Partner at Supernova Invest: «I am confident his strategic insights will be instrumental to the further development and growth of AcuSurgical»

Recommended AI News: Intel’s Silicon, Software Accelerate 5G, Edge

Comments are closed.